You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 324 BDB001, a Toll-Like receptor 7 and 8 (TLR7/8) agonist, can be safely administered intravenously and shows clinical responses in advanced solid tumors

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
324 BDB001, a Toll-Like receptor 7 and 8 (TLR7/8) agonist, can be safely administered intravenously and shows clinical responses in advanced solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020357039
Dec 202046015
Jan 202170013
Feb 202168015
Mar 202186016
Apr 202110809
May 202193036
Jun 20210044
Jul 20210032
Aug 20210025
Sep 20210022
Oct 2021102038
Nov 2021222046
Dec 2021122017
Jan 202288015
Feb 2022124015
Mar 2022258028
Apr 2022112014
May 2022116018
Jun 202278011
Jul 20229408
Aug 2022108018
Sep 202298011
Oct 20227405
Nov 202268012
Dec 202218809
Jan 20236005
Feb 2023110019
Mar 2023124021
Apr 202388019
May 20237208
Jun 202310609
Jul 202386011
Aug 2023132014
Sep 202392015
Oct 2023200028
Nov 2023144026
Dec 202310409
Jan 20247403
Feb 20249607
Mar 2024124010
Apr 202480013
May 20248609
Jun 202478015
Jul 20246409
Aug 20245004
Sep 20248204
Oct 20245606
Nov 202484014
Dec 2024160023
Jan 202582011
Feb 202526018
Mar 2025009
Apr 20250012
May 20250025
Jun 2025206
Total51420913